Background And Purpose: Proton radiotherapy (PRT) offers potential benefits over other radiation modalities, including photon and electron radiotherapy. Increasing the rate at which proton radiation is delivered may provide a therapeutic advantage. Here, we compared the efficacy of conventional proton therapy (CONV) to ultrahigh dose-rate proton therapy, FLASH, in a mouse model of non-small cell lung cancers (NSCLC).
Materials And Methods: Mice bearing orthotopic lung tumors received thoracic radiation therapy using CONV (<0.05 Gy/s) and FLASH (>60 Gy/s) dose rates.
Results: Compared to CONV, FLASH was more effective in reducing tumor burden and decreasing tumor cell proliferation. Furthermore, FLASH was more efficient in increasing the infiltration of cytotoxic CD8 T-lymphocytes inside the tumor while simultaneously reducing the percentage of immunosuppressive regulatory T-cells (Tregs) among T-lymphocytes. Also, compared to CONV, FLASH was more effective in decreasing pro-tumorigenic M2-like macrophages in lung tumors, while increasing infiltration of anti-tumor M1-like macrophages. Finally, FLASH treatment reduced expression of checkpoint inhibitors in lung tumors, indicating reduced immune tolerance.
Conclusions: Our results suggest that FLASH dose-rate proton delivery modulates the immune system to improve tumor control and might thus be a promising new alternative to conventional dose rates for NSCLC treatment.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527231 | PMC |
http://dx.doi.org/10.1016/j.radonc.2023.109741 | DOI Listing |
Med Phys
January 2025
Department of Radiation Oncology, Inha University Hospital, Incheon, Republic of Korea.
Background: High-dose-rate (HDR) brachytherapy using Iridium-192 as a radiation source is widely employed in cancer treatment to deliver concentrated radiation doses while minimizing normal tissue exposure. In this treatment, the precision with which the sealed radioisotope source is delivered significantly impacts clinical outcomes.
Purpose: This study aims to evaluate the feasibility of a new four-dimensional (4D) in vivo source tracking and treatment verification system for HDR brachytherapy using a patient-specific approach.
Phys Med Biol
January 2025
RaySearch Laboratories AB, Eugeniavägen 18C, Stockholm, 113 68, SWEDEN.
The advent of ultra-high dose rate irradiation, known as FLASH radiation therapy, has shown promising potential in reducing toxicity while maintaining tumor control. However, the clinical translation of these benefits necessitates efficient treatment planning strategies. This study introduces a novel approach to optimize proton therapy for FLASH effects using traveling salesperson problem (TSP) heuristics.
View Article and Find Full Text PDFHealth Phys
January 2025
China Medical University Hospital, No. 2, Yude Road, Taichung, Taiwan.
The shielding performance and activation susceptibility of a sandwich wall in the proton therapy facility of China Medical University Hospital were investigated in an integrated manner using FLUKA Monte Carlo simulations. The 2-m-thick partition wall between two adjoining treatment rooms had a three-layered structure, which comprised a 0.2-m-thick iron layer sandwiched between two layers of 0.
View Article and Find Full Text PDFPhys Med Biol
January 2025
Department of Oncology Radiation, University of California San Francisco, 1600 Divisadero Street, Suite HM006, San Francisco, California, 94143, UNITED STATES.
To study the effect of dose-rate in the time evolution of chemical yields produced in pure water versus a cellular-like environment for FLASH radiotherapy research. A version of TOPAS-nBio with Tau-Leaping algorithm was used to simulate the homogenous chemistry stage of water radiolysis using three chemical models: 1) liquid water model that considered scavenging of eaq-, H● by dissolved oxygen; 2) Michaels & Hunt model that considered scavenging of ●OH, eaq-, and H● by biomolecules existing in cellular environment; 3) Wardman model that considered model 2) and the chemical repair enzyme glutathione (GHS). H2O2 concentrations at conventional and FLASH dose-rates were compared with published measurements.
View Article and Find Full Text PDFFront Oncol
December 2024
Institute of Radiation Medicine (IRM), Helmholtz Zentrum München GmbH, German Research Center for Environmental Health, Neuherberg, Germany.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!